Antiphospholipid syndrome is an incurable autoimmune disease best known for increasing an individual’s risk of blood clotting events like stroke and pulmonary embolism. Somanathapura K. NaveenKumar, Ph.D, a postdoctoral researcher, led a team that identified two enzymes that seem to have lost their normal protective functions in patients with antiphospholipid syndrome.
